VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board

7 Mar 2018 - Yahoo News
ISNES, Belgium, March 7, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has further strengthened its Scientific Advisory Board with the addition of Dr. Lee-Jen Wei, a professor of Biostatistics at Harvard University. Prof. Wei's main area of research ...
usx:vnrx

---

VNRX: Q4 Results / Operational and Business Update

6 Mar 2018 - Yahoo News
By Brian Marckx, CFA NYSE:VNRX VolitionRx (NYSE:VNRX) reported Q4 results and provided a business update. Relative to the financials, results continue to come in well within our expectations with Q4 operating ...
usx:vnrx

---

VolitionRx Limited (NYSEMKT:VNRX): Are Analysts Optimistic?

2 Mar 2018 - Yahoo News
VolitionRx Limited’s (AMEX:VNRX): VolitionRx Limited, a life sciences company, focuses on developing blood-based tests to diagnose a range of cancers. The US$84.33M market-cap posted a loss in its most recentRead More...
usx:vnrx

---

VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update

1 Mar 2018 - Yahoo News
ISNES, Belgium, March 1, 2018 /PRNewswire/ -- VolitionRX Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results for the full fiscal year ended December 31, 2017. Cameron Reynolds, Chief Executive Officer of Volition, upon releasing these results commented, "I could not be more ...
usx:vnrx

---

VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update

28 Feb 2018 - Yahoo News
Conference call to take place Friday, March 2, 2018 at 8:30 am Eastern time ISNES, Belgium , Feb. 28, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) today announced it will host a conference ...
usx:vnrx

---

VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer - PR Newswire

26 Feb 2018 - PR Newswire

usx:vnrx

---

VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer

26 Feb 2018 - Yahoo News
This ongoing study is being carried out in collaboration with Hvidovre Hospital, University of Copenhagen, Denmark and involves 680 subjects from the Danish National CRC Screening Program. The interim results demonstrated that a small panel of three ELISA assays, when considered with the subjects' ages ...
usx:vnrx

---

VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.

5 Feb 2018 - Yahoo News
ISNES, Belgium, Feb. 5, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the successful conclusion to the Logistics and Pathway Design Study conducted by Hvidovre Hospital and The Danish Research Group. The study was established to answer the very practical, ...
usx:vnrx

---

Cancer Diagnostics group VolitionRX looks ahead to 2018 - Proactive Investors USA & Canada

4 Jan 2018 - Proactive Investors USA & Canada

usx:vnrx

---

VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone

3 Jan 2018 - Yahoo News
ISNES, Belgium, Jan. 3, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today released an important letter from Group CEO, Cameron Reynolds updating the company's shareholders. In the letter, Mr. Reynolds outlines several significant accomplishments to date and highlights ...
usx:vnrx

---